SIM
SRNE

Strategic Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Strategic Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,398
Closed -$177K – 141
2015
Q4 		$177K Buy
+20,398
New +$172K 0.1% 91

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Investment Management's SRNE Position: Q1 2016 in Review

Strategic Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2016, closing a stake of 20,398 shares — an estimated $177K sold.

Strategic Investment Management first reported a position in SRNE in Q4 2015 and held it in 1 quarter. The position peaked at $177K in Q4 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q1 2016.

  • Strategic Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Strategic Investment Management sold 20,398 Sorrento Therapeutics, Inc. shares in Q1 2016, an estimated $177K.
  • Strategic Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Strategic Investment Management's Sorrento Therapeutics, Inc. position peaked at $177K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2016.

Based on Strategic Investment Management's 13F filing for Q1 2016, filed 16 May 2016.